Recruiting BZLF1 Peptide Vaccine (OSU-2131) With QS-21 for the Prevention of Epstein-Barr Virus Related Cancer in Patients Awaiting Solid Organ Transplants NCT06741072 Conditions Chronic Disease, Chronic Kidney Disease, Stage 4, Chronic Kidney Disease, Stage 5, +14 more Locations Ohio State University Comprehensive Cancer Center — Columbus, Ohio, United States View Trial Details
